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ABSTRACT
Co-transcriptional imprinting of mRNA by Rpb4
and Rpb7 subunits of RNA polymerase II (RNAPII)
and by the Ccr4–Not complex conditions its post-
transcriptional fate. In turn, mRNA degradation fac-
tors like Xrn1 are able to influence RNAPII-dependent
transcription, making a feedback loop that con-
tributes to mRNA homeostasis. In this work, we have
used repressible yeast GAL genes to perform ac-
curate measurements of transcription and mRNA
degradation in a set of mutants. This genetic anal-
ysis uncovered a link from mRNA decay to tran-
scription elongation. We combined this experimental
approach with computational multi-agent modelling
and tested different possibilities of Xrn1 and Ccr4
action in gene transcription. This double strategy
brought us to conclude that both Xrn1–decaysome
and Ccr4–Not regulate RNAPII elongation, and that
they do it in parallel. We validated this conclusion
measuring TFIIS genome-wide recruitment to elon-
gating RNAPII. We found that xrn1Δ and ccr4Δ exhib-
ited very different patterns of TFIIS versus RNAPII oc-
cupancy, which confirmed their distinct role in con-
trolling transcription elongation. We also found that
the relative influence of Xrn1 and Ccr4 is different in
the genes encoding ribosomal proteins as compared
to the rest of the genome.
INTRODUCTION
Gene expression was thought to be a linear process where
each step came after the next without interfering in each
other’s paths. However, abundant studies have made it ev-
ident that these pathways are interconnected and can in-
fluence one another (reviewed in (1–3)). The coupling of
transcription and mRNA decay through transcription and
degradation factors is what we call cross-talk. This mech-
anism is thought to be important because it allows cells to
maintain mRNA levels within a certain limit despite vari-
ous perturbations that could occur inside or outside the cell
(4), and facilitates adaptation to new circumstances.
A few transcription factors have already been found to
be implicated in this cross-talk since they affect the fate of
nascent mRNA. This process has been named mRNA im-
printing (5), and the most prominent factors involved are
Rpb4/7, components of the RNA polymerase II (RNAPII)
(6) and the multifunctional Ccr4–Not complex (7). These
factors bind to the nascent mRNA in the nucleus, influenc-
ing its export into the cytoplasm, translation and degrada-
tion. Other factors have been linked to an opposite phe-
nomenon: stimulation of gene transcription after cytoplas-
mic degradation of mRNA. The most distinguished factors
that take part in this mechanism are Xrn1, the major 5′-
3′ exonuclease part of the decaysome complex (8,9), and
again, the Ccr4–Not complex, one of the major deadeny-
lases (10). Both complexes are part of the mRNA pathways
in the cytoplasm, yet have been found to shuttle into the nu-
cleus and modulate transcription initiation and/or elonga-
tion (4,11). Xrn1 has been shown to control mRNA degra-
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dation and synthesis of an important subset of the yeast
genome, acting as a synthegradase (12,13).
Interestingly, both of the main complexes involved in
mRNA imprinting have been found to interact (14). In the
nucleus, Rpb4/7 is necessary for the Ccr4–Not complex
to promote transcription elongation by reactivating back-
tracked RNAPII (15). RNAPII backtracking occurs when
the polymerase takes a few steps backwards, and the 3′ end
of the growing RNA chain becomes disengaged from the
catalytic site. In this event, the elongation complex becomes
paused and must resolve the situation before resuming tran-
scription. Transcription factor IIS (TFIIS), an RNA cleav-
age factor, can help resolve this situation by stimulating in-
trinsic hydrolysing activity of the polymerase, which cleaves
the backtracked 3′ stretch of the nascent RNA, allowing
transcription to restart from an upstream point (16). It
has been proposed that Ccr4–Not can also prevent back-
tracking and/or rescue backtracked RNAPII. However, it
is thought to do so in a different manner: by binding the
polymerase and realigning the transcript into the active cen-
tre (11). It may also act in cooperation with TFIIS (17).
RNAPII arrest and backtracking have been suggested to
be important for transcription regulation of genes (18,19).
Furthermore, RNAPII backtracking was found to be im-
portant for the recently demonstrated role of Ccr4–Not in
mRNA imprinting. The binding of the complex to nascent
mRNA can influence translation and subsequent degrada-
tion of mRNAs (7). These findings made RNAPII back-
tracking an interesting subject in the context of cross-talk
between transcription and mRNA decay.
Cross-talk of transcription, mRNA degradation and
translation has been mathematically modelled using a
stochastic kinetic approach (20). Their results favour the
circular gene expression hypothesis over the traditional
model of linear transcription and degradation, with Xrn1–
decaysome in the centre of the feedback regulation. Agent-
based simulation is an alternative way of modelling this
mechanism. This kind of simulation can deal with complex
systems made up of autonomous entities called agents (21).
In computation, agents are independent and autonomous,
with a capability to adapt and modify their behaviours.
They can move freely and interact with other agents or the
environment. The interaction of many agents in the same
environment leads to emergent properties of the system,
which were not previously defined. These emergent prop-
erties can provide information on the system dynamics and
allow us to draw conclusions.
Accurate measurement of mRNA decay is experimen-
tally difficult. It usually involves transcriptional shut-off
by stressing procedures, which can generate experimental
artefacts (22). However, mRNA decay of regulated genes
can be measured after physiological repression of the gene’s
promoter. In yeast cells growing in galactose-containing
medium, the GAL1 gene can be rapidly repressed by adding
glucose, allowing easy calculation of its mRNA half-life.
Although changing carbon sources may have some over-
all influence on mRNA stability (23), it seems not to affect
mRNA half-lives of GAL genes. In fact, mRNA half-life
measured after repression of a GAL gene driven by a TET-
off promoter produced very similar values in comparison
with the glucose shut-off method (24).
In this study, we first used a GAL1-based experimen-
tal approach to determine the transcriptional and degrada-
tion profiles of eight different mutants. These mutants were
specifically chosen because of their known involvement in
cross-talk and RNAPII backtracking. Then, we mathemat-
ically modelled this cross-talk using a multi-agent program-
ming language, NetLogo (25).
Here we show the diverse effects in transcription and
mRNA degradation caused by mutations in the transcrip-
tion or degradation machineries. This extensive study then
allowed us to find novel correlations linking RNAPII elon-
gation to mRNA half-life, which supports a functional
connection between transcription elongation and mRNA
degradation. Our multi-agent model also supports the idea
of a cross-talk between mRNA transcription elongation
and decay, where feedback regulation is carried out by Ccr4
and Xrn1, which we identify as important elements of the
mechanism. Both experimental and computational results
indicate that the influence of Xrn1 in this feedback mecha-
nism is not indirectly mediated by Ccr4 and that it may be
affecting RNAPII backtracking. We conclude that Xrn1–
decaysome and Ccr4–Not complexes play different roles in
the regulation of RNAPII transcription elongation.
MATERIALS AND METHODS
Strains and growth conditions
Saccharomyces cerevisiae strains used in this study are listed
in Supplementary Table S1. Strains were grown at 30◦C,
with liquid cultures growing in an orbital shaking incubator
at 180 rpm in YP medium (1% yeast extract, 2% peptone)
and containing either 2% galactose (YPGal) or 2% glucose
(YPD) as a carbon source. All the S. cerevisiae strains uti-
lized were in the BY4741 background.
For transcriptional shut-off assays, cells were grown in
YPGal for at least seven generations until reaching an
OD600 nm of ∼0.5. A sample was taken, and immediately
after, glucose 4% was added to the culture. Samples were
taken at the indicated times after glucose addition.
Determination of cell volume, number and growth
The median values of cell volumes were calculated by a
Coulter-Counter Z series device (Beckman Coulter, USA).
Cell number was determined by counting the number of
cells using a Neubauer chamber. Growth curves were done
for each mutant by measuring OD600 nm every 2 h for a total
of 5 time-points. The doubling time was estimated from this
growth curve (see Supplementary Table S1 for data).
RNA extraction and RT-qPCR
Cells were grown to log phase and 10 ml was harvested
by centrifuging for 2 min at 4000 rpm and flash freezing
the cells in liquid nitrogen. Total RNA was purified us-
ing hot phenol–chloroform method as described previously
(26) and reverse-transcribed to cDNA using M-MLV Re-
verse Transcriptase (Promega). A relative real-time quan-
titative PCR was then carried out for all the genes stud-
ied (Supplementary Table S2) against SCR1 using SYBR
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(Roche). Since SCR1 is an abundant and stable RNA that
has a constant concentration during cell growth (27), nor-
malization of mRNA values to SCR1 is an indirect way to
calculate apparent mRNA concentration ([mRNA]).
To determine the mRNA half-lives, we used a transcrip-
tion shut-off assay, collecting samples at 5, 10, 20, 30, 40, 50
and 60 min after glucose addition. mRNA levels were then
determined with RT-qPCR and half-lives were estimated by
calculating the time it takes for half of the initial amount of
RNA to be degraded. In all mutants analysed in this work,
the galactose/glucose signalling pathway was operative, as
detected by measuring the disappearance of RNAPII from
the 5′ end of GAL1p-YLR454w shortly after adding glucose
(see Supplementary Figure S3A). Nevertheless, in those mu-
tants where the signal did not immediately decrease, we cal-
culated the half-lives from minute 5.
Chromatin immunoprecipitation (ChIP)
Yeast strains were grown to exponential phase and 50 ml
were taken for each sample. The ChIP experiments were
performed as previously described (28), except that anti-
Rpb3 (ab81859; Abcam), anti-HA (3F10 Roche) or anti-
C-Myc (9E10 Santa Cruz Biotechnology) antibodies and
Sheep anti-Mouse or anti-Rat IgG Dynabeads (Invitrogen)
were used. Genes were analysed by quantitative real-time
PCR in triplicate using primers listed in Supplementary Ta-
ble S2.
To determine RNAPII speed, we performed a transcrip-
tion shut-off assay by quickly cross-linking the cells at 2,
3 and 4 min after glucose addition. In two cases the times
were 2, 3.5 and 5 min after stopping transcription. To ob-
tain RNAPII speed values, we divided each % IP value by
its previous time-point in order to take into account only
the polymerases that remain transcribing at each moment.
Using an engine at www.wolframalpha.com, we calculated
the area of RNAPII remaining on the gene in order to de-
termine how much RNAPII had left the gene at each time
point. To obtain the speed for each point, we divided the re-
sulting RNAPII amount by the time elapsed. Finally, for the
general RNAPII speed for each mutant, we determined the
weighted average of the RNAPII speeds calculated at each
time-point. By doing so, we minimized aberrant alterations
that might occur specifically either in early or late times of
this transcription run-off assay, as previously reported (29).
Transcription run-on
Run-on assays were performed as previously described (23)
with minor modifications. Basically, 25 ml of yeast culture
were collected at OD600 nm 0.5 by centrifugation. Cells were
washed twice in 5 ml of 0.5% sarkosyl solution for perme-
abilization, chromatin clearance and transcription ternary
complexes fixation. In vivo transcription was performed for
5 min at 30◦C by re-suspending cells in an appropriate
a transcription mix consisting of transcription buffer (50
mM Tris/HCl pH 7.7, 500 mM KCl, 80 mM MgCl2), ri-
bonucleotide mix (ATP, GTP and CTP of 10 mM each),
0.1 M DTT and [-32P]UTP (3000 Ci/mmol). The reac-
tion was stopped by adding 1 ml of cold water and RNA
was immediately extracted following the acid-phenol pro-
tocol. Slot-blotted membranes were elaborated as formerly
described (28), with double-strand immobilized probes pre-
viously obtained by PCR using primers listed in Supple-
mentary Table S2. The phosphorimaging analyses were per-
formed in a STORM-840 imaging system (GE Health-
care) and quantified using GelQuant.NET software pro-
vided by www.biochemlabsolutions.com. All run-on signals
were normalized to radiolabelled DNA signals and to the
number of cells harvested in each mutant.
Western blot
Laemmli-boiled crude extracts were run on a SDS-
polyacrylamide gel and transferred to nylon membranes
(Hybond-ECL). After blocking with Tris-buffered saline
containing 0.1% Tween 20 and 5% milk, the following
primary antibodies were used: mouse monoclonal anti-
HA 16B12 (ab130275; Abcam), mouse monoclonal anti-
Rpb3 (ab81859; Abcam) or mouse monoclonal anti-Pgk1
22C5D8 (Invitrogen). Finally, the membrane was incubated
with peroxidase-conjugated goat anti-mouse IgG and pro-
teins were detected using a chemiluminescence detection kit
(Super-Signal West Pico, Pierce) and a ChemiDoc™ MP sys-
tem (Bio-Rad).
Calculations and statistics
All results were calculated and represented using Microsoft
Excel. The statistics were carried out using SPSS. A Stu-
dent’s t-test was used to determine significant differences
between biological samples. When correlating variables, a
Spearman regression coefficient was carried out using a
two-tailed significance test.
The R package BayesVarSel (https://CRAN.R-project.
org/package=BayesVarSel) was used to perform a Bayesian
analysis of the inclusion probabilities among some of the
variables. We used the Bvs function of this package.
Principal components analysis was performed to deter-
mine possibly correlated variables or mutants. This was
done using the ‘prcomp’ function in R.
In silico experiments
NetLogo in its latest version (currently 6.0.2) (https://ccl.
northwestern.edu/netlogo/) was used to program and run
the model. SPSS in its latest version to conduct statistical
analysis of the results both in experimental data and in in
silico data obtained with the model.
ChIP-seq
ChIP of both HA-TFIIS and Rpb3 were performed in
parallel with the same cell extract, sharing the same in-
put. Two biological replicates of each strain were done and
an untagged strain was used as a control. The resulting
DNA was sent to CRG Genomics Unit where libraries
were prepared and sequenced in an Illumina HiSeq 2000
instrument to an output of 1713.8 (1 × 50) million reads.
The quality metrics of the Fastq sequencing datasets were
obtained with FastQC and visually inspected. After de-
multiplexing, sequencing adapters were removed from raw
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trimmed with Sickle, and then PCR duplicates were re-
moved with Fastx Collapser to ensure each fragment was
represented only once. A second round of inspection with
FastQC was carried out after the filtering steps to verify
that the filters were applied properly. The remaining high
quality sequences were mapped to the SacCer3 genome with
Bowtie2, using default parameters. Resulting BAM align-
ment files were visually inspected with the genome browser
IGV (www.broadinstitute.org/igv/). Normalized coverage
tracks for genome browser visualization were generated
with the functions bamCoverage and bamCompare from
the deepTools2 suite. Coverage tracks from individual sam-
ples are expressed as reads per kilobase per million mapped
reads (RPKM), whereas comparison tracks are expressed as
the log2 of the number of reads ratio. Normalized average
density plots around genomic features were calculated with
the ngs.plot package (30). The ChIP-seq mode and the sta-
tistical robustness parameter, which filters out 0.5% of genes
with the most extreme expression values, were applied to all
calculations. The average occupancy profiles of IP and no-
tag samples were compared to each other to verify that both
profiles were different. No-tag datasets were not used for
any further downstream analysis. Based on the high similar-
ity of the average occupancy profiles from the two biological
replicates, the two datasets from each sample were merged
into one for average metagene representations around ge-
nomic regions with SamTools (31). The ngs.plot tool was
also used to generate bell-shaped heat map representations
centred around gene midpoints.
Chromatin-enriched fractions
Chromatin-enriched fraction purification was performed
according to the yChEFs procedure (32). Briefly, 150 ml of
exponentially growing yeast cells (OD600 ∼ 0.7–0.8) were
harvested, at least in triplicate. The whole final purified
chromatin-enriched fraction P3 was resuspended in 20 l
of 1× Tris-Glycine SDS Sample Buffer and incubated for
5 min at 100◦C, followed by spinning at 10 000 rpm for
30 s. This chromatin pellet was used for SDS-PAGE, fol-
lowed by western blotting with different antibodies: anti-
C-Myc (9E10 Santa Cruz Biotechnology), anti-Rpb3 (anti-
POLR2C; 1Y26, Abcam), anti-Histone H3 (ab1791; Ab-
cam) or anti-phosphoglycerate kinase, Pgk1 (459250; Invit-
rogen). Histone H3 was used as a control of purified chro-
matin and Pgk1 as a control of cytoplasmic contamination.
RESULTS
GAL1 [mRNA] resists most perturbations of synthesis and
decay
Simultaneous analysis of mRNA synthesis and decay is dif-
ficult, since most methods for measurement of mRNA half-
life involve stressful inhibition of global cell transcription or
incorporation of nucleotide analogues that can affect both
transcription and mRNA stability. GAL genes can be es-
pecifically shut-off by adding glucose. We decided to use
GAL1 as a suitable model to study the effect of mRNA
degradation mutants on transcription elongation and vice
versa. We studied the response of GAL1 to the genetic per-
turbation of mRNA decay and transcription elongation
machineries by measuring parameters that define the differ-
ent levels of the gene expression pathway. We studied mu-
tants lacking Xrn1, the main cytoplasmic 5′-3′ exoribonu-
clease (33); Ccr4, the main cytoplasmic deadenylase and a
subunit of the Ccr4–Not complex (10); Not4, another com-
ponent of this complex (34) that controls de ubiquitylation
and degradation of arrested RNAPII (35); Dhh1, an RNA
helicase involved in several steps of the mRNA cycle that is
tightly associated with both de decaysome (9,22) and Ccr4–
Not complexes (36,37); Dst1/TFIIS, a transcription factor
able to stimulate the resolution of RNAPII backtracking
events (38); Sfp1, a transcription factor that stimulates ex-
pression of most growth-related genes and that function-
ally interacts with TFIIS (39); and Pfd1, a subunit of the
prefoldin complex that contributes to chromatin dynamics
during elongation and also displays a strong functional in-
teraction with TFIIS (40). We also included a point mu-
tant of Rpb1 (rpb1-I756A), in which we have changed an
amino acid involved in the interaction between the 3′ end
of pre-mRNA and a conserved domain of RNAPII when
this is backtracked (41) (Supplementary Figure S1). This
mutation does not map in the active centre of RNAPII
and, therefore, its phenotypes should not be due to the
catalytic defects exhibited by other RNAPII elongation-
defective mutants (29,42).
For every mutant, we calculated total RNAPII occu-
pancy of the GAL1 gene body by anti-Rpb3 ChIP, density
of actively elongating RNAPII molecules by transcriptional
run-on, and apparent [mRNA] and mRNA half-life by RT-
PCR of samples taken several times after adding glucose
to cells exponentially growing in galactose (Supplementary
Figure S2A). We also calculated RNAPII speed in each mu-
tant using the GAL1p-YLR454w system, in which one of
the longest genes of the yeast genome is driven by a GAL
promoter (43) (Supplementary Figure S3A–C). The com-
plete set of values obtained in this study can be found in
the Supplementary Data, and a summary of the results for
each mutant normalized to the wild-type is shown in Sup-
plementary Figure S2B.
Significant changes in RNAPII occupancy, active
RNAPII density and mRNA half-life where found in most
mutants analysed. However, apparent [mRNA] levels were
much less affected indicating a robust homeostasis in most
cases (Figure 1A–E). Only xrn1Δ, not4Δ and rpb1-I756A
exhibited significantly altered apparent [mRNA] suggest-
ing that Xrn1, Ccr4–Not and the backtracking-related
domain of RNAPII are particularly relevant for mRNA
homeostasis (Figure 1A). In fact, xrn1Δ and rpb1-I756A
were the only two mutants affected in all the parameters
measured, including RNAPII speed (Figure 1E).
Very similar results were obtained when we analysed the
GAL1p-YLR454w gene (Supplementary Figure S4A–D). In
this case, however, apparent [mRNA] was also significantly
decreased in dst1Δ, ccr4Δ, pfd1Δ and sfp1Δ, which was ex-
pected for mutants functionally linked to RNAPII elonga-
tion and that strongly affect the expression of long genes
(40,44).
We wondered if [mRNA] was preferentially associated
with any of the other four parameters measured in this
work. We plotted apparent [mRNA] of GAL1 in each strain
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Figure 1. GAL1 mRNA levels resists most perturbations of synthesis and decay. (A) GAL1 mRNA levels in exponential cultures of the indicated mu-
tant strains. Apparent [mRNA] was calculated relative to SCR1 by RT-qPCR. (B) Total RNAPII occupancy as measured by anti-Rpb3 ChIP. Each bar
represents the average value of four amplicons across the GAL1 gene. (C) Active RNAPII as measured by the incorporation of radioactive 32UTP (tran-
scriptional run-on). The bars represent the average value of four probes across the GAL1 gene. (D) GAL1 mRNA as measured by RT-qPCR before and
after shutting off transcription by glucose. Half-lives were determined by calculating the time it takes for half of the initial mRNA to be degraded. (E)
RNAPII speed as measured by anti-Rpb3 ChIP in the long GAL1p-YLR454w gene before shutting off transcription, and three times afterwards. Values
were normalized to time 0, and RNAPII speed was calculated. All bars represent mean and standard deviation of three biological replicates (* if p < 0.05
in a Student’s t-test). (F–I) To the right of each of the previous graphs, we have represented the corresponding variable with respect to apparent [mRNA].
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RNAPII and RNAPII speed values, and we looked for sta-
tistical association. No significant correlation was found af-
ter Spearman’s test between [mRNA] and any of the four
parameters analysed, demonstrating that none of them pre-
dicts [mRNA] on its own (Figure 1F–I).
Since no correlation was detected so far, we wondered
whether our data were too noisy due to technical reasons.
We decided to analyse the correlation between synthesis
rates, formulated as the density of nascent transcription di-
vided by cell volume (see (22) for details) and degradation
rates, calculated from apparent [mRNA] and mRNA half-
life. We found a very significant correlation between these
two parameters in our set of mutants (Supplementary Fig-
ure S5A). This correlation was improved even more when
RNAPII speed was considered for the calculation of synthe-
sis rates (Supplementary Figure S5B). Interestingly, the cor-
relation was further enhanced when xrn1Δ or rpb1-I756A
were removed from the data (Supplementary Figure S5C).
Altogether, these results confirm that alterations of mRNA
synthesis can be to a large extent compensated at the degra-
dation step and vice versa.
We have previously described that cell volume influences
nascent transcription and mRNA degradation rates (45).
To test if our data reproduced this observation, we calcu-
lated the correlation between mRNA half-life and cell vol-
ume. We found a significant positive correspondence (Sup-
plementary Figure S6A). We also found a negative cor-
relation between the density of active RNAPII molecules
(transcription run-on signal) and the cell volume (Supple-
mentary Figure S6B). We have also described that growth
rate stimulates global transcription (46). Accordingly, we
found a positive correlation between the total amount of
RNAPII bound to GAL1 in each strain to the respective
growth rates (GR) (Supplementary Figure S6E). However,
total RNAPII occupancy (Rpb3 ChIP signal) did not cor-
relate with cell volume (Supplementary Figure S6C); and
active RNAPII did not correlate with GR (Supplementary
Figure S6C and D). This suggests a regulatory link between
GR and gene transcription at the level of PIC formation,
which limits the number of RNAPII molecules transcrib-
ing the gene, whereas the connection between transcription
and cell volume would be mediated by the fraction of ac-
tively elongating RNAPII molecules. On top of these sug-
gestions, the correlations detected confirmed that our data
are not noisy.
RNAPII elongation parameters correlate with mRNA half-
life
The correlations of cell volume with mRNA half-life (pos-
itive, Supplementary Figure S6A), and active RNAPII lev-
els (negative, Supplementary Figure S6B) predict a neg-
ative correlation between the latter. We found it indeed
(Figure 2A). In contrast, we found no correlation between
mRNA half-life and total RNAPII occupancy (Figure 2B).
The ratio between active and total RNAPII (RNAPII spe-
cific activity) also negatively correlates with mRNA half-life
(Figure 2C). Since the differences between active and total
RNAPII molecules have to be caused by inactivation (likely
by backtracking) during elongation, these results suggest a
link between mRNA synthesis and degradation at this step
of transcription.
Co-transcriptional mRNA imprinting has been shown
to connect mRNA synthesis and decay (4,47). It has been
proposed that RNAPII backtracking might modulate this
imprinting (7). Increased backtracking has been shown to
decrease RNAPII speed (19). Thus, we looked for and
found a negative correlation between RNAPII speed and
mRNA half-life when using data from all mutants (Figure
2D). Since RNAPII speed (negatively) and mRNA half-
life (positively) both correlated with cell volume (Figure 2D
and Supplementary Figure S6F, respectively), we performed
Bayesian analysis to rule out the possibility that the corre-
lation between speed and mRNA half-life was mediated by
cell volume. Speed and volume together explained mRNA
half-life better than cell volume alone, while cell volume
is better explained by half-life alone (Supplementary Table
S3).
We have shown that growth rate stimulates mRNA de-
cay (46). In fact, reduced mRNA stability in some RNAPII
mutants is due to their limited growth rate (29). We won-
dered if the negative correlation between RNAPII speed
and mRNA half-life was due to growth alterations. How-
ever, we found no correlation between RNAPII speed and
growth rates (Supplementary Figure S6G).
Negative correlation of mRNA half-life with RNAPII
specific activity was higher than with speed, due to the out-
lier behaviour of not4Δ and rpb1-I756A data points. not4
lacks a subunit of the Ccr4–Not complex, which has been
shown to mediate mRNA imprinting (7). It decreased ac-
tivity without affecting speed. rpb1-I756A decreased speed
without affecting activity. As a consequence of these and
other mutants, RNAPII speed and specific activity did not
correlate (Figure 2E). Our RNAPII elongation speed mea-
surements are based on ChIP experiments with the GAL1p-
YLR454w system after promoter shut-off. Since this sys-
tem can be confounding in some specific mutants (29), lack
of correlation between RNAPII speed and specific activity
should be considered cautiously. Even so, our results sug-
gest that the functional connection between transcriptional
elongation and mRNA decay is complex and might involve
other phenomena in addition to mRNA imprinting.
Multi-agent modelling predicts an additional regulatory con-
nection from mRNA decay to transcription elongation medi-
ated by Xrn1
Physical interaction of Xrn1 to promoter regions has been
reported and Xrn1 has been proposed to activate PIC as-
sembly and/or RNAPII initiation (9). Accordingly, the
transcriptional phenotypes of xrn1Δ might be a combina-
tion of its direct effect on initiation and an indirect effect
on elongation, mediated by Ccr4–Not, the only mRNA
decay factor that has been demonstrated so far to stim-
ulate RNAPII elongation (11). We constructed a multi-
agent model based on these functional interactions (Sup-
plementary Figure S7A). We defined the properties of each
agent (gene, RNAPII, mRNA, TFIIS, Ccr4–Not, Xrn1)
and constructed an in silico model using the NetLogo pro-
gramming language (see Supplementary Data: Multi-agent
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Figure 2. Speed and activity of elongating RNAPII correlates with mRNA half-life. Scatter plots comparing normalized values of the mutants mentioned
in Figure 1 for active RNAPII versus mRNA half-life (A), total RNAPII occupancy versus mRNA half-life (B), RNAPII specific activity (active/total
ratio) versus mRNA half-life (C), RNAPII speed versus mRNA half-life (D) and RNAPII speed versus RNAPII specific activity (E). Plots (A), (C) and (D)
all showed negative correlations, whilst (B) and (E) presented no significant correlation. In all graphs, the ρ represents the Spearman coefficient. P-values
are also shown. Colour code like in Figure 1.
responding flow charts (Supplementary Figure S7B). All
agents move and interact in a 3D space divided in two
concentric compartments that represent the nucleus and
the cytoplasm (Supplementary Figure S7C, Supplemen-
tary Data: 3D-model video). Gene, polymerases and TFIIS
are confined in the nucleus, whereas mRNAs can go out
of the nucleus and be degraded in the cytoplasm. Xrn1
and Ccr4–Not can move to the nucleus by roaming after
they finish degrading mRNAs in the cytoplasm (Supple-
mentary data: Multi-agent models). A single gene and six
RNAPII molecules were established. The relative number of
molecules of TFIIS, Ccr4 and Xrn1 was adjusted according
to the information available in the literature, in comparison
to the molecules of RNAPII (Supplementary Data: Multi-
agent models). These parameters can be modified in the in-
terface, allowing us to test the effect of eliminating any fac-
tor (in silico mutant) (Supplementary Figure S7D). Some
other parameters that are specific of each agent (radius of
action, probability of RNAPII backtracking or to reacti-
vate spontaneously) can also be set in the interface. A num-
ber of monitors describe in real time the state of the system:
fraction of time that the gene is occupied by an RNAPII;
mean time (number of ticks) needed by a RNAPII to com-
plete a transcription cycle; proportion of time that elongat-
ing polymerases are backtracked; mRNA half-life; average
number of mRNA molecules (Supplementary Figure S7D).
The evolution of the latter over time can be visualized in
a window of the interface (Supplementary Data: computa-
tional experiment video). This allows confirming in every
experiment one of the expected emerging properties of the
system: a steady state number of mRNA molecules, where
synthesis and degradation rates are equivalent (Supplemen-
tary Figure S7D).
The first model that we constructed (model 1) involved
a positive action of nuclear Xrn1 molecules on transcrip-
tion initiation, without subsequent action of this factor in
elongation (Figure 3A). Regarding the action of nuclear
Ccr4, we defined four different variants of the model. In
the first case the interaction of Ccr4–Not with an actively
elongating RNAPII prevented any backtracking. In the
second variant, the interaction of Ccr4–Not with a back-
tracked RNAPII molecule promoted its reactivation. In
the third case, the interaction of Ccr4–Not with a back-
tracked RNAPII molecule stimulated the recruitment of
TFIIS, which in turn reactivated the enzyme (Figure 3A).
The fourth and last variant refers to a model where there
is no feedback at all by Ccr4-Not. After performing their
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Figure 3. Multi-agent modelling predicts an additional connection from mRNA decay to transcription elongation. (A) Scheme showing the possible
interactions of the degradation machinery with the transcription machinery conforming the different model variants. An arrow indicates that Xrn1 can
stimulate RNAPII initiation. Other arrows indicate Ccr4–Not action where it can either (i) prevent backtracking, (ii) reactivate backtracked RNAPII or (iii)
cooperate with TFIIS in reactivating backtracked RNAPII. TFIIS has also been included in this model. It reactivates backtracked RNAPII. (B) Matrices
showing the in vivo data and the in silico data for one of the best scoring model variants (Ccr4–Not reactivates backtracked RNAPII and Xrn1 presents
feedback to the promoter of genes). We compared total mRNA, mRNA half-life, Total RNAPII, Active RNAPII and RNAPII speed in the dst1Δ, ccr4Δ
and xrn1Δ mutants. If any value was not significantly different from the wild-type, then a 0 was assigned to that variable and mutant. If it was significantly
different, then a −1 or +1 was assigned depending on if the number was significantly larger or smaller than that of the corresponding wild-type value. A
Student’s t-test was carried out to compare values and were considered significant if p< 0.05. The hits with respect to the in vivo data add 1 point to the
overall score. Those values that vary with respect to the in vivo data do not change the score, unless it is a −1/+1 difference where 1 point is taken away
from the overall score. (C) Table showing the scores obtained in the first mathematical model when we compare the model variants to the in vivo data.
The columns indicate whether Xrn1 presents feedback to the gene promoter (yes) or not (no). The rows indicate the Ccr4–Not action undertaken. The
models were scored as indicated in (B), with a maximum possible score of 15. In all cases, there was Ccr4–Not imprinting. (D) Scheme illustrating how
the second model was programmed. A0 represents the active RNAPII. Xrn1 can act upon this active RNAPII, turning it into Ax, an RNAPII that does
not backtrack and in consequence transcribes faster. If Xrn1 does not act, then the RNAPII can become inactive (I). If TFIIS or Ccr4–Not does not act,
then the RNAPII turns into a backtracked polymerase (Ib) and eventually drops-off the gene. If TFIIS is present, it can reactivate the polymerase before it
drops-off. If Ccr4–Not is present, it can interact with RNAPII and allows it to stay in active transcription. (E) Matrix showing the in silico data obtained
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of the nucleus to act in mRNA degradation. In the case
of Ccr4–Not, it can bind mRNA to be exported together
(mRNA imprinting) or can detach from RNAPII at the ter-
minator and move outside of the nucleus (see later). We per-
formed 100 in silico experiments and calculated the mean
values of five characteristic parameters of the system once
it reached steady state mRNA levels, using the informa-
tion provided by the monitors in the interface: number of
mRNA molecules, mRNA half-life, total occupancy of the
gene by RNAPII, occupancy by active (non-backtracked)
RNAPII molecules and RNAPII speed. We repeated these
experiments under conditions of no TFIIS, Ccr4–Not or
Xrn1 molecules (in silico dst1Δ, ccr4Δ and xrn1Δ mutants).
We compared the values obtained with the in silico wild-
type and calculated a data matrix reflecting the differences:
0 meant no significant difference with the wild-type using a
Student’s t-test (P < 0.05), and +1 or -1 meant significantly
increased/decreased values, respectively (Figure 3B). A sim-
ilar matrix was made with the results of the in vivo experi-
ments of the GAL1 gene described above (Figure 3B). We
reasoned that the comparison of the two matrices should
reflect the similarity between the model and the situation
in vivo. In order to quantify this similarity, we calculated a
score, counting all values that coincided in the two matri-
ces (excluding the wild-type), and subtracting one point in
those cases where a -1/+1 difference was found.
Maximal possible score was 15 and the best score ob-
tained was 9, corresponding to the second and third vari-
ant of Ccr4–Not action (Figure 3B and C). However, the
other variant showed no drastic difference (Figure 3B and
C). We also performed similar experiments under condi-
tions where Xrn1 did not have the ability to stimulate ini-
tiation. In all variants of the model, lack of Xrn1 action
produced some decrease in the global score (Figure 3C),
supporting a role of Xrn1 at this level. The minimal score
that was obtained was 5, when neither Xrn1 nor Ccr4–Not
presented any feedback to transcription elongation (Figure
3C). Therefore, the comparison of in vivo and in silico results
supported transcriptional contributions of mRNA degra-
dation factors. Nevertheless, the highest score obtained was
still 6 points short of the maximum possible score of 15.
This indicated that this first model was far from fully ex-
plaining the transcriptional functions of Xrn1 and Ccr4-
Not. Particularly relevant was the observation of RNAPII
speed and active RNAPII. In all variants, these two parame-
ters behaved the same, since the only restriction for RNAPII
speed in this model was backtracking, which also resulted in
lack of activity. However, in vivo results showed that ccr4Δ
and dst1Δ caused a decrease in RNAPII activity without
significant reduction in speed (Figure 3B). In fact, xrn1Δ
was the only mutant tested with a significant decrease in
speed.
In all variants described above, once Ccr4–Not interacted
with the polymerase it remained bound and was transferred
to mRNA after termination, simulating an mRNA imprint-
ing process. We repeated the in silico experiments, eliminat-
ing this mRNA imprinting. The scores obtained were not
higher in any case, and in some cases the action of Xrn1
was detrimental (Supplementary Figure S7E). So, lack of
fitness of the model was not due to introducing mRNA im-
printing.
We decided to design a second multi-agent model with
some changes. We distinguished a new state of elongating
RNAPII conferred by interaction with nuclear Xrn1 dur-
ing initiation that prevents backtracking and/or inactiva-
tion (Figure 3D). Those polymerases that would not receive
this Xrn1 stimulus would be prone to inactivation (giving
low activity results in transcriptional run-on experiments)
and would be sensitive to backtracking. In addition, the
previous RNAPII state would be suppressed by the inter-
action with nuclear Ccr4–Not, rendering elongating poly-
merases insensitive to backtracking and less prone to inac-
tivate, although slower than those molecules enhanced by
Xrn1 (Figure 3D; Supplementary Data: Multi-agent mod-
els). We tested this second model and generated a new ma-
trix of in silico results. Comparison with the matrix of in vivo
results produced a global score of 12, after only three mis-
matches and no −1/+1 penalty (Figure 3E). Altogether, the
results of the multi-agent modelling supported a contribu-
tion of Xrn1 to transcription elongation, not mediated by
Ccr4–Not.
xrn1Δ and ccr4Δ differentially alter RNAPII elongation
The multi-agent results prompted us to come back to the
experimental evidence showing the involvement of Xrn1 in
transcription elongation. First, we performed a clustering
analysis of all the experimental data accumulated so far and
summarized in Supplementary Figure S2B, based on Spear-
man correlations. We found that mRNA decay mutants did
not cluster together and that xrn1Δ primarily associated
with rpb1-I756A, a mutant specifically affected in the back-
tracking domain of RNAPII (Figure 4A). We also carried
out a principal component analysis of the same data. In this
case ccr4Δ, not4Δ and xrn1Δ grouped, but they did it to-
gether with dst1Δ. In fact, xrn1Δ and dst1Δ were the clos-
est mutants in this group (Figure 4B). Thus, two different
analyses of the experimental data support a functional con-
nection of Xrn1 to transcription elongation and RNAPII
backtracking, suggesting that Xrn1 may regulate transcrip-
tion by altering elongation rates.
Some mutants causing transcription elongation defects
are hypersensitive to NTP-depleting drugs, like 6-azauracil
(6AU) (48). We tested sensitivity to different concentration
of 6AU for all mutants analysed in this work. As described,
we found that dst1Δ, ccr4Δ and not4Δ were hypersensitive
to 50–100 g/ml 6AU (Supplementary Figure S8A) (49,50).
We also found no 6AU sensitivity for sfp1Δ and pfd1Δ,
as reported (Supplementary Figure S8A) (39,40). dhh1Δ
showed moderate hypersensitivity, as it was unable to grow
at 100 g/ml 6AU, whereas xrn1Δ did not show any de-
crease in viability in the presence of the drug, at any concen-
tration tested (Supplementary Figure S8A). However, when
we combined ccr4Δ and xrn1Δ in the same strain we found
a dramatic hypersensitive phenotype, since the double mu-
tant ccr4Δ xrn1Δ was unable to grow at 5 g/ml 6AU (Sup-
plementary Figure S8A). These data support a contribution
of Xrn1 to transcription elongation, in the context of pre-
viously reported interactions between ccr4Δ and RNAPII
elongation mutants (50). In fact, we also found a synthetic
interaction between ccr4Δ and rpb1-I756A. In this case, the
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Figure 4. Lack of Xrn1 phenotypically associates with lack of TFIIS and provokes fast inactivation of elongating RNAPII. (A) Spearman hierarchical
clustering of all the data summarized in Supplementary Figure S2B. xrn1Δ primarily associates with rpb1-I746A. (B) A principal component analysis of
the same data associates mRNA decay mutants with dst1Δ. The first component (PC1) explains 52.94% of the variables and the second component (PC2)
the 24.48%. (C) Active RNAPII along the GAL1 and GAL1p-YLR454w gene is decreased in an Xrn1-AID strain, where Xrn1 is rapidly depleted from the
cell upon the addition of auxin. Here, we compare the control (-AUX) to Xrn1-depleted cells (+AUX). (D) Total RNAPII is unaffected along the GAL1
and GAL1p-YLR454w genes when comparing control to Xrn1 depleted cells. (E) The mRNA half-life of GAL1 and GAL1p-YLR454w is significantly
increased upon Xrn1 depletion. (F) Apparent [mRNA] of both genes is also increased upon Xrn1 depletion. (G) Cell volume is unaffected after depleting
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but the double ccr4Δ rpb1-I756A mutant was drastically hy-
persensitive to this drug (Supplementary Figure S8B).
6AU hypersensitivity is a meaningful phenotype fre-
quently due to transcription elongation defects. However, it
is also connected to transcription initiation defects in some
RNAPII mutants (29). In order to further characterize the
transcriptional involvement of Xrn1, we looked for more di-
rect molecular evidence. So far all Xrn1 results shown were
based on the analysis of deletion mutants, which involved
a significant limitation in growth. The single xrn1Δ showed
3.0 h doubling time in YPD at 30◦C, versus 1.8 h of the
wild-type. This growth defect was even more severe in the
double ccr4Δ xrn1Δ mutant, with a doubling time of 8.6 h.
These growth defects usually originate pleiotropic pheno-
types that are only indirectly related to the genetic change.
In order to exclude these possible side effects, we decided
to analyse the effect of Xrn1 fast depletion with an engi-
neered version of Xrn1 that is fused to an AID domain
and become rapidly degraded in respond to auxin, a non-
metabolized molecule. We treated an Xrn1-AID strain for 1
h with auxin and explored its effect on GAL1 mRNA syn-
thesis and decay. We found a substantial increase in mRNA
half-life and [mRNA], which indicated fast and effective
degradation of Xrn1 after adding the drug. We also detected
decreased density of active RNAPII molecules on GAL1,
down to <20% of the untreated value, without a significant
change in total RNAPII occupancy (Figure 4C–F). Very
similar results were obtained for GAL1p-YLR454w (Figure
4C–F). No change in cell volume was detected at this time,
which indicates that the transcriptional downregulation in-
duced by Xrn1 depletion was not an indirect consequence of
cell volume alteration (Figure 4G). These results confirmed
a functional link between Xrn1 and RNAPII activity dur-
ing elongation.
Low transcription activity with unchanged levels of total
RNAPII density strongly suggests increased RNAPII back-
tracking. This predicts higher recruitment of TFIIS to tran-
scribing RNAPII molecules. In fact, significantly higher
TFIIS/RNAPII ratios were found on GAL1 in xrn1Δ, but
not in ccr4Δ (Figure 5A; Supplementary Figure S9A and
B). This increased recruitment of TFIIS is not due to higher
levels of TFIIS in xrn1Δ cells (Figure 5B). Other mutants
causing low RNAPII occupancy of GAL1 but no decrease
in the activity of elongating RNAPII molecules, like sfp1Δ
or dhh1Δ (Figure 2C), did not exhibit significantly higher
TFIIS/RNAPII ratios (Figure 5C; Supplementary Figure
S9C and D). In contrast, not4Δ, which prevents the pro-
teolytic removal of arrested RNAPII complexes (35) and
originates a severe decrease in the activity of elongating
RNAPII molecules, like xrn1Δ (Figure 2C), did show a
marked increase of TFIIS/RNAPII ratios in GAL1 (Fig-
ure 5C; Supplementary Figure S9C and D). This indicates
that the TFIIS/RNAPII ratio is not unspecifically due to
decreased RNAPII occupancy but is a useful parameter to
follow defects in RNAPII elongation.
These results support a regulation of RNAPII elongation
in response to mRNA decay alterations that is not mediated
by Ccr4. In fact, no significant changes in the levels of Ccr4
present in chromatin were detected in xrn1Δ (Supplemen-
tary Figure S10A). And no reduction in Ccr4 occupancy of
GAL1 was found (Figure 5D). If any, some light increase in
the Ccr4/Rpb3 ratios on GAL1 seems to happen in xrn1Δ
(Supplementary Figure S10B).
So far, all experiments have been performed with a model
gene. In order to extend our conclusions to the whole
genome, we analysed TFIIS/RNAPII ratios by ChIP-seq
in xrn1Δ and ccr4Δ. We confirmed overall higher levels of
TFIIS/Rpb3 in xrn1Δ than in the wild-type, whereas in
ccr4Δ we detected the opposite effect (Figure 6A and B).
Moreover, we detected significant differences in the profiles
of TFIIS/Rpb3 ratios along genes. The wild-type displayed
an asymmetric profile, with minimum levels in the 3′ end
of genes (Figure 6A). This asymmetric profile was particu-
larly clear in genes containing TATA-like motives in their
core promoters, and was enhanced in xrn1Δ, which showed
stronger increase than the wild-type in the 5′ half of the gene
bodies (Figure 6C). In contrast, ccr4Δ exhibited a symmet-
ric profile, with similarly low ratios in 5′ and 3′ ends (Figure
6A–C). The 5′ effect of ccr4Δ was more evident in TATA-
like than in canonical TATA genes like GAL1 (Figure 6C).
Finally, we analysed TFIIS/Rpb3 ratios in other gene
families. In the wild-type, genes encoding factors involved
in ribosome biogenesis (RiBi) and ribosomal proteins (RP)
exhibited lower TFIIS/Rpb3 ratios than the rest of the
genome (Figure 7A). In xrn1Δ quantitative alterations were
detected for TATA-like, canonical-TATA and RiBi genes,
in comparison to the wild-type, but no increase was de-
tected in RP genes (Figure 7B). In contrast, TFIIS/Rpb3
ratios of ribosome-related genes increased in ccr4Δ, with
RP genes situated clearly above the rest of the genome (Fig-
ure 7C). So, TFIIS/Rpb3 ratios of RP genes behaved differ-
ently than the rest of the genome in both xrn1Δ and ccr4Δ
(Figure 7D). This is a qualitative difference of RP genes
that is not due to its high transcription rate, since the top
transcribed quartile of genes (excluding RP genes) exhibited
completely different profiles (Supplementary Figure S11A–
C).
Since we did not detect a general increase in recruitment
of TFIIS to elongating RNAPII on RP genes in xrn1Δ, we
predicted that Xrn1 perturbation should not affect the ac-
tivity of elongating RNAPII molecules in this gene cate-
gory. We tested this prediction by quantifying levels of total
RNAPII bound to several RP genes, by anti-Rpb3 ChIP,
before and after depleting Xrn1-AID with auxin. We also
measured the density of active RNAPII molecules on the
same genes, by transcription run-on, in the same cultures.
In contrast to GAL1 and GAL1p-YLR454w (Figure 4C and
D), we found no significant changes in either total or ac-
tive RNAPII in RPS3, RPS8, RPL5 and RPL25 (Figure 7E
and F). This indicates that transcription elongation of RP
genes is not impaired by Xrn1 perturbation. In combination
with our genome-wide analysis, these results confirmed that
Xrn1 and Ccr4 contributes to transcription elongation in a
differential manner, exhibited by both their effects on elon-
gating RNAPII molecules and the subset of genes affected.
DISCUSSION
In this work, we have used GAL1 as a model gene to care-
fully investigate the effect of a set of mRNA degradation
and transcription mutants on gene expression. This analysis
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Figure 5. xrn1Δ and ccr4Δ cause different effects on TFIIS recruitment to elongating RNAPII. (A) The amount of TFIIS/Rpb3 found on the GAL1 gene
is significantly increased in an xrn1Δ mutant. This was not the case for ccr4Δ, as the values were similar to that of the wild-type. ChIPs were performed
for HA-TFIIS and Rpb3 using the same cell extract in parallel. We were then able to directly compare the amounts of TFIIS and Rpb3 in each strain. The
bars represent the mean and standard deviation of three biological replicates (* if p < 0.05 in a Student’s t-test). (B) The total protein levels of TFIIS/Rpb3
is reduced in ccr4Δ and xrn1Δ mutants compared to the wild-type. We performed a western blot of total extract proteins and used an antibody against a
HA tagged TFIIS, Rpb3 and Pgk1 (loading control). The bars represent the mean and standard deviation of three biological replicates (* if p < 0.05 in a
Student’s t-test). (C) The TFIIS/Rpb3 ratio found on the GAL1 gene is significantly increased in a not4Δ mutant. No changes compared to the wt were
observed for other mutants tested: dhh1Δ and sfp1Δ. Results obtained as in (A). (D) Ccr4 occupancy of GAL1 was not altered by lack of Xrn1. ChIPs
were performed using anti-C-Myc antibodies. The bars represent the mean and standard deviation of three biological replicates. Values were small but
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Figure 6. The mRNA decay mutants ccr4Δ and xrn1Δ show distinct alterations of TFIIS/Rpb3 along genes in a genome wide analysis. (A) Whole genome
metagene analysis shows that ccr4Δ and xrn1Δ present different TFIIS/Rpb3 profiles. Lines represent the mean profile of TFIIS/Rpb3 along all yeast
genes in wild-type, ccr4Δ and xrn1Δ strains. TSS is the transcription start site of genes and TES the transcript exit site. The profile is represented as the
log2 of the fold change between the TFIIS ChIP and the Rpb3 ChIP. (B) The mapping of TFIIS/Rpb3 in five different genes shows an opposite effect
for xrn1Δ and ccr4Δ. There is an increased signal for xrn1Δ than for the wild type in this region of the genome. However, when we turn our attention
to ccr4Δ, we can observe the opposite in the same positions. (C) A genome wide study (ChIP-seq) of TFIIS/Rpb3 on genes shows a different profile for
ccr4Δ, xrn1Δ and the wild type. We have represented all yeast genes ordered by gene length, which leads to a bell shape, and separated out four different
groups of genes depending on their promotor type (TATA or TATA-like genes, and within the latter, we seperated out ribosomal protein (RP) genes and
ribosome biogenesis (RiBi) genes). In the wt we can observe a downregulation of TFIIS/Rpb3 mostly at the 3’ end of genes, and an upregulation in the
5’ ends. We obtained a similiar profile for xrn1Δ, although with a stronger effect at 5’ ends. However, in ccr4Δ downregulation of TFIIS/Rpb3 occurs at
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Figure 7. Transcription elongation in RP genes is differentially influenced by Xrn1 and Ccr4, as compared with other gene categories. (A) Whole genome
metagene analysis of the wild-type shows changes in the TFIIS/Rpb3 profile depending on the gene category. We have represented with a line the mean
profile of TFIIS/Rpb3 along all yeast genes. We then divided up the genes into different categories depending on their type of promoter: TATA or TATA-
like genes, excluding ribosomal protein genes (RP) or ribosomal biogenesis genes (RiBi). The RP and RiBi genes seem to behave differently from the rest
of the genes, with lower overall amounts of TFIIS throughout the entire metagene. TSS is the transcription start site of genes and TES the transcript exit
site. The profile is represented as the log2 of the fold change between the TFIIS ChIP and the Rpb3 ChIP. ChIPs of HA-TFIIS and Rpb3 were performed
using the same cell extract and in parallel. We represent the mean of two biological replicates. (B) Whole genome metagene analysis of the TFIIS/Rpb3
ChIP in xrn1Δ. We have represented the same analysis as in (A) but for the xrn1Δ mutant. (C) Whole genome metagene analysis of the TFIIS/Rpb3
ChIP in ccr4Δ. We have represented the same analysis as in (A) but for the ccr4Δ mutant. In this case, RP genes show higher TFIIS/Rpb3 ratios than
the rest of genes, and RiBi genes behave the same as all genes. (D) The mapping of TFIIS/Rpb3 on the RPS11A and YDR026C genes show a distinct
effect for xrn1Δ and ccr4Δ. In the top part of the panel, we can observe the occupancy of TFIIS/Rpb3 in the wild-type and xrn1Δ. For the most part,
there is similar occupancy in xrn1Δ and the wild-type. However, there is clearly decreased signal for ccr4Δ (at the bottom of the panel) at the exact same
positions. (E and F) Xrn1 rapid depletion by auxin did not perturb Rpb3 occupancy (E) or activity (F) in RP genes. We performed ChIP against Rpb3 and
transcriptional run-on in the AID Xrn1-degron strain without (-AUX) or with (+AUX) auxin addition for 1 h. No significant differences between samples
were detected. These Rpb3 ChIP and transcription run-on experiments are directly comparable as the same yeast culture was used for both experiments.
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homeostasis when challenged by genetic perturbations that
alter mRNA synthesis or degradation. This analysis al-
lowed us to detect new links between mRNA decay and
transcription elongation. It has been described that nascent
mRNA molecules associate with Rpb4/7 (5,6) and Ccr4-
Not (7) during elongation, conditioning its future trans-
lation and subsequent degradation. RNAPII backtracking
may influence this process. Correlations detected in our data
set uncovered a complex relationship between mRNA half-
life, RNAPII activity during elongation and RNAPII speed
(Figure 2C and E), suggesting that other regulatory links
between mRNA decay and transcription elongation might
exist. While mRNA imprinting allows controlling mRNA
decay from gene transcription (5,12), this additional links
might work in the opposite direction, regulating transcrip-
tion elongation from mRNA decay.
The simplest hypothesis to explain such putative regu-
lation would involve that one or more components of the
mRNA degradation machinery might be able to interact
with RNAPII and control its elongation behaviour. We hy-
pothesize that, under conditions of long mRNA half-life
due to stochastic oscillations, the subsequent mRNA ac-
cumulation would make the decay machinery to be totally
engaged in degradation. In this situation, no free factors
would be available to migrate to the nucleus and foster
transcription elongation. In contrast, under the shortage
of [mRNA] provoked by short half-life, the pools of free
degradation factors would be higher, allowing them to move
into the nucleus and stimulate transcription elongation. A
similar model has been proposed for the control of nu-
clear RNA metabolism (51) but can be extended to mRNA
metabolism, provided that degradation factors are able to
shuttle between the cytoplasm and the nucleus. At least two
mRNA decay factors, Ccr4–Not and Xrn1–decaysome, are
able to move to the nucleus and interact with the transcrip-
tion machinery. Ccr4 stimulates transcription elongation
by direct interaction with elongating RNAPII (11,15) and
cooperates with TFIIS to rescue backtracked polymerases
(17). Our computational multi-agent modelling, however,
indicated that these two functions of Ccr4 (mRNA imprint-
ing and enhancement of RNAPII elongation) are not suf-
ficient to fully explain our experimental data. Incorpora-
tion of Xrn1–decaysome to the model, assuming its role in
fostering elongation, provided a better explanation of the
data. Additional functions of these factors, like the role of
Ccr4–Not in RNAPII assembly (14), might improve future
versions of the model. To the best of our knowledge, the
utilization of multi-agent modelling to simulate molecular
biology interactions is an original methodological contribu-
tion of this work.
We have also previously reported evidence showing a
functional link between Xrn1–decaysome and transcrip-
tional elongation. Mutants lacking Xrn1 or containing a
catalytically dead allele preferentially affect transcription
of long genes and show altered profiles of RNAPII along
gene bodies (9,13). However, these phenotypes might be in-
directly caused by side effects of the lack of Xrn1 function in
mRNA degradation; for instance, by decreasing the pool of
nuclear Ccr4|Not able to act on elongation. Our results indi-
cate that this is not the case. Fast depletion of Xrn1 caused
dramatic decrease of elongating RNAPII activity in GAL1
without diminishing growth or increasing cell volume (Fig-
ure 4B–F). The levels of Ccr4 occupancy on gene bodies
or Ccr4 in the chromatin fraction did not change in cells
lacking Xrn1 (Figure 5C and Supplementary Figure S10A).
Moreover, lack of Ccr4 did not produce higher recruitment
of TFIIS to elongating RNAPII molecules in GAL1 (Figure
5A). Genome-wide analysis also showed that lack of Ccr4
did not increase TFIIS recruitment to elongating RNAPII
(Figure 5D and 6C). In contrast, lack of Xrn1 did produce
higher TFIIS/Rpb3 ratios in GAL1 (Figure 5A) and across
the genome (Figures 5D and 6B), in spite of its lower cellu-
lar levels (Figure 5B).
We have previously shown that transcriptional action of
Xrn1–decaysome requires its transport into the nucleus (9),
and that Xrn1 binds the GAL1 gene body upon transcrip-
tional induction (13). Xrn1 is also recruited to the gene
bodies of osmotic-responsive genes during induction (Paula
Alepuz, personal communication). This evidence suggests
that Xrn1 action on elongating RNAPII would involve its
physical interaction with elongating RNAPII. Proteomic
analysis of RNAPII elongation complex has reported such
an interaction (52), which is also supported by genetic evi-
dence (53). Both physical and genetic interactions between
Xrn1 and other factors directly involved in transcription
elongation have been reported. In amongst these factors are
the CTD kinases Ctk1 (54,55) and BUR (55,56), the chro-
matin remodeller Isw1 (57) and the histone modifying com-
plex SAGA (58,59). It is, therefore, conceivable that Xrn1
may foster transcription elongation by favouring the struc-
tural transition that the RNAPII elongation complex un-
dergoes between promoter escape and transcription termi-
nation (60,61). This transition involves the re-configuration
of the of RNAPII/Spt6/DSIF/PAF quaternary complex.
An action of Xrn1 at this level would be fully compati-
ble with a parallel role by Ccr4, since this factor binds the
Rpb4/Rpb7 module of RNAPII and acts on the emerg-
ing transcript (15) and the N-terminus domain of recruited
TFIIS (17).
Since Xrn1 is a 5′ to 3′ RNA exonuclease, it is also
tempting to speculate that Xrn1 may favour eviction of
irreversibly arrested RNAPII molecules by some kind of
torpedo mechanism of termination. If this would be the
case, Xrn1 would need the previous action of the decap-
ping machinery, which also seems to participate in mRNA
decay/transcription cross-talk (9). However, we cannot ex-
clude Xrn1 influences transcription elongation at a distance.
From its reported location in promoter regions (9), Xrn1
might indirectly enhance elongation by antagonizing anti-
sense ncRNAs, many of which are shown to accumulate in
Xrn1-deficient mutants (62). Efforts should be made to ad-
dress these hypotheses in the near future.
In our hands, lack of Ccr4 provoked decreased RNAPII
activity in GAL1, without decreasing RNAPII speed and
without increasing TFIIS recruitment. Lack of Xrn1 also
caused decreased RNAPII activity in GAL1, but with in-
creased TFIIS recruitment and enlengthened elongation
rate. These differences indicate that Ccr4 and Xrn1 foster
elongation in different manners. Moreover, lack of TFIIS
does not significantly decrease RNAPII speed, in spite of
its significant impact on nascent transcription rates and
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slowest mutant in our hands, rpb1-I756A, did not show de-
creased RNAPII activity. This suggests that in the context
of our experimental conditions backtracking tendency, as
it is detected by the run-on assay, is not the main limita-
tion of speed. It may contribute in some cases, but other
events like RNAPII/nucleosome interaction, nascent RNA
dynamics or even the length of the backtracking move-
ment, might be more rate-limiting for speed. According to
this, reduced RNAPII speed and increased backtracking
frequency would be two different aspects of the elongation
defects of xrn1Δ. The success of our second multi-agent
model, which is based on this hypothesis, supports this view.
Enhanced RNAPII backtracking of xrn1Δ would pro-
duce the higher recruitment of TFIIS that we detected in
GAL1 and across the genome. In contrast, lack of Ccr4 did
not produce such an effect in either GAL1 or our global
analysis, but a general decrease of the TFIIS/Rpb3 ratios
in most genes. This fits with the reported role of Ccr4 in fa-
cilitating the recruitment of TFIIS to elongating RNAPII
(17).
While lack of Xrn1 originated a general increase in the re-
cruitment of TFIIS along gene bodies in our genome-wide
study, lack of Ccr4 caused opposite 5′ versus 3′ changes in
the distribution of TFIIS, with special incidence in TATA-
like genes (Figure 5D; Supplementary Figure S9A and B).
This is consistent with the biased 5′/3′ distribution of active
RNAPII reported for ccr4Δ in a wide set of highly tran-
scribed genes (28). The differential effect of Xrn1 and Ccr4
is also consistent with their distinct association with the
RNAPII elongation complex in a model gene, whereas Ccr4
was reported to specifically bind the 3′ half of the gene body,
Xrn1 was found to evenly associate to elongating RNAPII
from 5′ to 3′ (52).
Unexpectedly, RP genes behaved differently to most
other genes in ccr4Δ when classified according to
TFIIS/Rpb3 ratio, which increased in this group of
genes (Figure 6C). It points to a particularly important
contribution of Ccr4 to elongation in RP genes. It has
been described that RP mRNAs are also especially prone
to be imprinted by Ccr4–Not (7), suggesting that co-
transcriptional imprinting and stimulation of RNAPII
elongation by Ccr4–Not can be coupled phenomena.
RP genes also behaved differentially with respect to Xrn1,
since lack of this factor did not increase TFIIS/ratios in this
subset of genes, and fast Xrn1 depletion did not reduce the
occupancy or activity of the RNAPII molecules engaged in
all RP genes that we tested (Figure 7). Since TFIIS/RPB3
ratios of RP genes are particularly sensitive to Ccr4 alter-
ation, these results contradict once more that Xrn1 acts on
elongation in a Ccr4-dependent manner.
This differential response of RP genes to changes in
mRNA decay fits with their behaviour in the context of
growth rate. We have described that transcription and
mRNA degradation rates increase in parallel with growth
rates, keeping [mRNA] unchanged, and have proposed that
this parallelism is due to the molecular cross-talk between
the transcription and mRNA decay machineries (64,65). We
have also proposed that RP genes can upregulate their ex-
pression with growth rate because they can disconnect from
this cross-talk. The specificity of RP genes that we have de-
tected backs this hypothesis.
All the evidence described in this work supports elongat-
ing RNAPII as an important target of the cross-talk be-
tween mRNA decay and gene transcription, and indicates
that, in addition to Ccr4, Xrn1 is an important player of this
molecular dialogue.
DATA AVAILABILITY
Our multi-agent software tools can be download from https:
//github.com/danther/Transcription-Degradation.
The ChIP-seq data are stored in the the GEO repository
(accession number GSE127179).
Data can also visualized in the UCSC browser: http:
//genome-euro.ucsc.edu/s/jorplan/xrm1 ChIP%2Dseq
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We thank Fernando Sancho and Joaquı́n Borrero (ETSI-
Universidad de Sevilla) and Jaime de Miguel (Cultura Dig-
ital) for advice on multi-agent modelling, and Paula Alepuz
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Choder,M. and Pérez-Ortı́n,J.E. (2014) Cytoplasmic 5′-3′ exonuclease
Xrn1p is also a genome-wide transcription factor in yeast. Front.
Genet., 5, 1.
14. Villanyi,Z., Ribaud,V., Kassem,S., Panasenko,O.O., Pahi,Z.,
Gupta,I., Steinmetz,L.M., Boros,I. and Collart,M.A. (2014) The
Not5 Subunit of the Ccr4-not complex connects transcription and
translation. PLoS Genet., 10, e1004569.
15. Babbarwal,V., Fu,J. and Reese,J.C. (2014) The Rpb4/7 module of
RNA polymerase II is required for carbon catabolite repressor
protein 4-negative on TATA (Ccr4-Not) complex to promote
elongation. J. Biol. Chem., 289, 33125–33130.
16. Nudler,E. (2012) RNA polymerase backtracking in gene regulation
and genome instability. Cell, 149, 1438–1445.
17. Dutta,A., Babbarwal,V., Fu,J., Brunke-Reese,D., Libert,D.M.,
Willis,J. and Reese,J.C. (2015) Ccr4-Not and TFIIS function
cooperatively to rescue arrested RNA Polymerase II. Mol. Cell Biol.,
35, 1915–1925.
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Stochastic kinetics of the circular gene hypothesis: Feedback effects
and protein fluctuations. Math. Comput. Simul., 133, 326–336.
21. Hinkelmann,F., Murrugarra,D., Jarrah,A.S. and Laubenbacher,R.
(2011) A mathematical framework for agent based models of complex
biological networks. Bull. Math. Biol., 73, 1583–1602.
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